Insider Buying: agilon health, inc. (NYSE:AGL) Director Purchases 25,000 Shares of Stock

agilon health, inc. (NYSE:AGL) Director Karen Mcloughlin purchased 25,000 shares of the firm’s stock in a transaction dated Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the purchase, the director now owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This represents a 51.90 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.

agilon health Trading Up 1.4 %

AGL traded up $0.03 during trading on Friday, reaching $2.25. The company had a trading volume of 3,068,318 shares, compared to its average volume of 4,856,405. The firm’s 50-day simple moving average is $2.46 and its 200 day simple moving average is $4.42. The company has a market cap of $927.05 million, a price-to-earnings ratio of -2.39 and a beta of 0.51. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $13.76.

agilon health (NYSE:AGL) last announced its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period last year, the firm earned ($0.06) earnings per share. Equities research analysts anticipate that agilon health, inc. will post -0.52 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. TD Cowen lowered their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Evercore ISI lowered their price objective on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Royal Bank of Canada reiterated an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a report on Tuesday, November 19th. Finally, Stifel Nicolaus lowered their target price on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a report on Tuesday, November 12th. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, agilon health presently has a consensus rating of “Hold” and an average price target of $4.38.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AGL. State Street Corp grew its holdings in shares of agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after acquiring an additional 215,733 shares in the last quarter. Geode Capital Management LLC increased its holdings in agilon health by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after buying an additional 84,889 shares during the last quarter. Citigroup Inc. raised its position in agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares in the last quarter. AQR Capital Management LLC grew its position in agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares in the last quarter. Finally, Barclays PLC lifted its stake in shares of agilon health by 21.2% in the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock valued at $4,830,000 after purchasing an additional 214,830 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.